Thompson Jaye has filed 15 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 149818 shares of Greenwich LifeSciences, Inc. ($GLSI) on December 24, 2024.
Activity breakdown: 14 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 24, 2024 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | A | Stock Options | 149818 | $0.00 | 299,636.0000 | 0 | 100.00% | 0.00% |
| Nov. 21, 2024 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 1000 | $12.91 | 264,148.0000 | 0 | 0.38% | 0.00% |
| Aug. 12, 2024 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 800 | $13.85 | 263,148.0000 | 0 | 0.30% | 0.00% |
| Aug. 2, 2024 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 1000 | $15.15 | 262,348.0000 | 0 | 0.38% | 0.00% |
| July 18, 2024 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 1000 | $16.00 | 261,348.0000 | 0 | 0.38% | 0.00% |
| Oct. 27, 2023 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 500 | $8.57 | 260,348.0000 | 0 | 0.19% | 0.00% |
| Sept. 26, 2023 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 600 | $8.71 | 259,848.0000 | 0 | 0.23% | 0.00% |
| July 13, 2023 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 250 | $9.49 | 259,248.0000 | 0 | 0.10% | 0.00% |
| April 28, 2023 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 250 | $11.22 | 258,998.0000 | 0 | 0.10% | 0.00% |
| April 11, 2023 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 1000 | $11.87 | 258,745.0000 | 0 | 0.39% | 0.00% |
| March 15, 2023 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 250 | $12.71 | 257,745.0000 | 0 | 0.10% | 0.00% |
| Feb. 24, 2023 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 250 | $15.40 | 257,495.0000 | 0 | 0.10% | 0.00% |
| Feb. 3, 2023 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 250 | $20.84 | 257,245.0000 | 0 | 0.10% | 0.00% |
| Jan. 27, 2023 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 250 | $19.20 | 256,995.0000 | 0 | 0.10% | 0.00% |
| Jan. 13, 2023 | Greenwich LifeSciences, Inc. | $GLSI | Thompson Jaye | VP Clinical Reg Affairs | P | Common Stock | 250 | $16.50 | 256,745.0000 | 0 | 0.10% | 0.00% |